Bespak has announced the launch of the Syrinaâ„¢ AR 2.25 auto-injector. This innovative auto-injector is the latest addition to the VapourSoftâ„¢ -powered Syrina range and is suitable for delivering ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced positive results of a clinical study demonstrating subcutaneous administration of 10 mL of a representative biologic product ...
The global auto-injectors market is rapidly evolving, emerging as one of the most dynamic segments of medical devices and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results